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Introduction
Globally, the relative burden of mental health disorders is on 
the rise in terms of prevalence, disability and mortality (1), 
with limited controlled data available to guide treatment 
choices for clinicians worldwide. Since the 1990s, electronic 
service delivery within healthcare has expanded significantly (2). 
This mode of service delivery initially received a number 
of titles such as ‘Telemedicine’, ‘Telehealth’ and ‘Telecare’. 
However, with the merging of different technologies, the 
whole area is becoming more encompassing and the term 
‘eHealth’ has emerged. 
One particular form of eHealth is mHealth (mobile 
Health), the Global Observatory for eHealth (GOe) defines 
mHealth or mobile health as ‘medical and public health 
practice supported by mobile devices, such as mobile phones, 
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patient monitoring devices, personal digital assistants (PDAs), 
and other wireless devices’ (3). mHealth technologies utilise 
components and functionalities of mobile devices such as 
Short Messaging Service (SMS), General Packet Radio 
Service (GPRS), Bluetooth, Global Positioning Systems 
(GPS) and mobile connectivity (3 and 4 g) and smartphone 
applications more commonly known as mobile Apps. 
mHealth has been successfully used in delivering treatment 
modalities in a variety of settings, predominantly in High 
Income Countries (HICs). In recent years, there have 
been studies on the successful use of a variety of mHealth 
interventions for Severe Mental Illness (SMI). More 
recently, a number of apps for psychosis have been launched 
e.g.; TechCare, Actisist and ClinTouch (4-6).
Mental, Neurological, Substance use (MNS) disorders 
constitute 14% of the global burden of disease (7). Low 
resourced countries face greater challenges to overcoming 
this burden due to lack of resources and limited availability 
and access to mental health care (8). The treatment gap 
for MNS disorders is estimated to be over 75% in many 
LMICs, due to the inequitable and insufficient usage of 
resources (1). mHealth technologies may be a potentially 
beneficial avenue to bridging this large treatment gap, 
through improved access to self-management and self-help 
interventions utilising digital clinical technologies, which 
may also significantly assist in recovery from SMI such as 
psychosis.
Individuals with a diagnosis of psychosis may experience 
a number of symptoms, such as auditory hallucinations 
and delusional ideation (9). Research has suggested the 
prevalence of psychosis to be roughly 1% globally (10). 
Psychotic illnesses are usually preceded by a prodrome 
which can last anywhere from one to three years (11), 
with individuals experiencing a wide range of non-
specific behavioural and psychological symptoms, and a 
deterioration in functioning (12). Interventions that prevent 
or delay transition to psychosis from the prodromal phase, 
may be clinically and economically important (13).
mHealth interventions have been used in the assessment 
and treatment of psychosis. A recent review by Alvarez-
Jimenez et al. (14) highlighted a number of mobile 
interventions for psychosis. However the focus of the paper 
was in relation to web based and social media interventions 
and did not take into account mobile devices as defined 
above. Another review conducted by Kasckow et al. (15) 
also reported the feasibility of telephone, the internet and 
videoconferencing interventions. However, these reviews 
focused more on eHealth interventions which are in most 
cases dependant on an internet connection. Globally only 
34.3% (16) of the global population have access to the 
internet whereas the International Telecommunication 
Union (ITU) estimates roughly 7 billion mobile phone 
subscriptions being held worldwide, with an estimated 
penetration of 96% of individuals having access to 
mobile phones globally (17). It can therefore be seen that 
mobile devices could be a potentially effective modality 
in providing health interventions, by bridging the gap for 
those individuals who do not have access to the internet in 
low resourced settings. 
The aim of this review is to search the literature 
systematically for studies utilising different mHealth 
interventions for psychosis ;  to assess what kind of 
interventions have been used globally. We believe a 
synthesis of available information could lead to a better 
understanding of the feasibility and effectiveness of these 
techniques in the treatment and assessment of psychotic 
illnesses. The results may help develop similar approaches 
for use in other mental illnesses, to reduce the burden of 
mental health disorders globally. 
Methods
Inclusion and exclusion criteria
We followed the Cochrane collaboration guidelines on 
conducting systematic reviews (18). The inclusion criteria 
for studies was based on the following criteria: (I) described 
the use of a mobile device intervention in patients who were 
suffering from psychosis (II) at least one outcome measure 
was the assessment and treatment of psychosis (III) was a 
controlled trial (randomised or quasi-randomised). Studies 
were excluded if they used internet or other technologies 
without utilising mobile devices such as smartphones and 
tablets. 
Literature search
We searched the following databases; Embase, Medline, 
PsychINFO and Evidence Based Medicine Reviews. A 
number of keywords were searched in each of the databases 
from inception to May 2016; the search criteria was initially 
configured and deployed in Medline and the same search 
criteria was then extrapolated to other databases. The key 
words that were searched included; ‘mHealth’ ‘Mobile 
Health’ or ‘SMI’ or ‘Schizophrenia’ or ‘Schizo-Affective 
Disorder’ or ‘Intervention’ or ‘Assessment’ or ‘Treatment’. 
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(Please see Supplementary for full search strategy). We also 
searched for relevant systematic reviews in the Cochrane 
Database of Systematic Reviews and the Cochrane Database 
of Abstracts of Reviews of Effects (DARE) and randomised 
controlled trials were searched in the Cochrane Central 
Trials Register (CENTRAL). 
Assessment of methodological quality
The methodological quality of the included randomised 
controlled trials and clinical controlled trials were assessed 
using the list from the Cochrane Risk of Bias Tool (19), 
which included 4 domains comprising of 11 criteria which 
assess internal validity of the selected studies. The 4 
domains that were examined and the criteria used are as 
follows: (I) selection bias; this domain looked at whether 
an adequate randomisation procedure was used, similarity 
in baseline data on the primary indicator and whether 
treatment allocation was concealed; (II) performance bias; 
this included blinding of patients to the intervention, 
whether intervention compliance was adequate, and whether 
health professionals/therapists were blinded to intervention 
groups (IG); (III) attrition bias; this domain looked at 
whether the study included an intention to treat analysis and 
whether the study had an acceptable level of dropout rate at 
baseline; (IV) detection bias this domain examined whether 
the study used similar or the same outcome measures 
across the study groups, and whether the outcome assessor 
was blinded to the study groups. Overall, the studies were 
scored independently by two of the researchers (NG & 
PSK) across each of the 4 domains, the studies were scored 
either with a ‘Yes’, ‘No’ or ‘Unclear’. Studies which scored 
more than 6 across each of the 4 domains were classed as 
high quality otherwise the remaining studies were classed as 
low quality. Any disagreements were discussed with senior 
researchers (SF, NH & JD) until a consensus was reached.
Data synthesis
The data was extracted from the databases and all abstracts 
were read by two of the research associates (NG & PSK). 
Those studies which met the inclusion criteria were 
then extracted by the reviewers using a standardised data 
extraction sheet. The following variables were extracted 
from the included studies; mobile Intervention used, type of 
study, outcome measures, duration, diagnostic criteria and 
results. Any disagreements were resolved through discussion 
with two investigators, (SF & NH) until consensus was 
gained. We had plans to conduct a meta-analysis, but in 
view of the nature of studies (see below), no meta-analysis 
was conducted.
Results
Characteristics of the included studies
We found a total of 5,690 titles across the databases we 
searched, using our search strategy, from these, 43 studies 
were selected based on the title and abstract for further 
scrutiny. We selected 23 studies which were read full text, 
with sixteen studies being excluded (see Figure 1). Out of 
the excluded studies, four studies were excluded as they did 
not include a randomised controlled design, these included 
a study by Pijnenborg et al. (20) which investigated an SMS 
text message intervention for cognitive rehabilitation in 
schizophrenia. A study by Depp et al. (21) which looked 
at the mobile assessment of psychotic symptoms coupled 
with a low intensity intervention and Ben-Zeev et al. (22) 
who looked at retrospective multiple real-time/real-place 
assessments using a dual methods design, in individuals with 
schizophrenia and a non-clinical group. Another excluded 
study by Palmier-Claus et al. (5) investigated ambulatory 
assessment of psychotic symptoms. Other reasons for 
excluded studies are given in Figure 1.
The 7 included studies examined different parameters, 
one of the studies used an Experiential  Sampling 
Methodology (ESM) which looked at  monitoring 
symptoms real-time, one looked at medication adherence, 
two looked at cognitive impairments, one looked at social 
functioning, one looked at suicidal ideation in veterans with 
schizophrenia, one looked at mobile phone text message 
reminders and one examined relapse prevention and early 
warning signs. In view of the widely different interventions 
and outcome measures it was not possible to conduct a 
meta-analysis. Therfore we decided to give a descriptive 
account of the results. 
Main findings
The characteristics of included studies are given in Table 1. 
The majority of studies were conducted across Europe and 
the United Sates with one in China; one was conducted 
in the UK, two in Spain, one in Finland, one in the 
Netherlands, one in China and one in the United States. 
Four of the studies were conducted in outpatient psychiatric 
settings, and three studies in an inpatient psychiatric unit. 
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The total population across all studies was 1,105 (Mean 
=158, SD =197.20), with 637 males (Mean =91, SD =92.58) 
and 468 females (Mean =67, SD =107.27), the mean age 
of participants was 35.35 (SD =8.73). Five studies used a 
randomised controlled trial design, one used a prospective 
randomised open-label controlled trial and one was quasi-
randomised. (Please see Table 1 for the main findings of the 
included studies).
mHealth interventions
The included studies used a number of differing delivery 
platforms. Ainsworth et al. (23) aimed to compare two 
differing mediums of receiving assessment notifications 
on a mobile phone device. The smartphone was loaded 
with a software application which provided questions to 
assess symptoms of psychosis. The system either utilised 
SMS text messages or smartphone based application to 
deliver the assessment questions. The study used a repeated 
measures crossover design which assigned the 24 study 
participants to either undergo the SMS condition first and 
then the smartphone application condition or vice versa. 
Both conditions used the same assessment questions which 
were based on the Positive and Negative Syndrome Scale 
(PANSS). 
Another included study conducted by Dang et al. (24) 
examined the effects of an iPad assisted cognitive 
training programme on working memory in a group of 
male first-episode (FEP) schizophrenia patients. The 
training programme included user-friendly iPad games 
such as “Shanghai Mahjong”, “Little Ace and the Ten 
Commandments”, “Math vs. Brains” and “Brain Teaser 
Extreme. Participants engaged in the cognitive training for 
60 minutes a day, 5 days a week. Assessments of working 
memory was conducted at baseline and follow up (week 4) 
through the N-Back task.
In addition, a total of four studies used a SMS based 
system as a delivery platform for the intervention (25-28). 
Pijnenborg et al .  (25) investigated the efficacy of 
SMS messages to provide prompts to participants to 
achieve goals in their daily lives. These goals included, 
medication adherence, appointments, activities, attending 
training sessions and inhibition of undesired behaviours. 
Achievement of goals was based on an observer filling 
in a score sheet which indicated whether the goal had 
been achieved or not. The information technology aided 
relapse prevention in schizophrenia (ITAREPS) (26) used a 
multicentre randomised controlled trial design to examine 
5690 records identified through 
database searching
EBM Reviews: 1542
EMBASE: 2375
Medline: 945
PsychInfo: 828
Total of 16 full-text articles 
excluded
Non-randomised design (n=4)
Non-Mobile Intervention (n=4)
Protocol papers (n=7)
Qualitative study (n=1)
4599 Records after duplicates removed
43 Records screened
Total of 23 full text articles 
assessed for eligibility
4556 Records excluded based 
on title
20 Records excluded
7 Studies included in final 
analysis
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Figure 1 Consort diagram to show search results.
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Table 1 Main findings of the included studies
Author Year Population
mHealth delivery 
method
Outcome measures used Main findings
Ainsworth 
et al.
2013 N=24 Smartphone 
application and 
mobile phone
Purpose-designed 
Quantitative Feedback 
Questionnaire to assess 
the acceptability and 
feasibility of these 
methods was used. 
Positive and Negative 
Symptom Scale (PANSS)
Participants in the smartphone application 
condition took significantly less time to complete 
the assessment questions (Mean =68.4 seconds, 
SD =39.5) compared to the SMS only condition 
(Mean =325.5 seconds, SD =145.6) (β=0.78, SE 
=0.09, P<0.001). There was also a significant 
difference in data points completed in the 
smartphone app group compared to the SMS only 
group (β=−0.25, SE =0.11, P=0.02). There was 
no significant difference in PANSS score across 
the domains Hallucinations Anxiety Grandiosity 
Delusions Paranoia, Hopelessness
Dang et al. 2014 iPad assisted 
cognitive training 
group: N=8; 
Control group: 
N=9
Tablet device N-Back performance 
was recorded as an 
accuracy rate, composed 
of the percent of correct 
responses (%) and 
reaction time for each 
response (ms)
Participants in the experimental group significantly 
improved in accuracy rate at 2-back (Z =−3.27, 
Pcorrected b 0.01), and reaction time in 0, 1 and 
2-back (Z =−2.89, Pcorrected =0.012; Z =−2.60, 
Pcorrected =0.048; Z =−2.98, Pcorrected =0.012, 
respectively) from baseline to week 4, compared 
to the control group
Kasckow  
et al.
2016 Telehealth (Health 
Buddy) group: 
N=25; Control 
group: N=26
Handheld 
mobile device
Questionnaire items 
assessing participants 
positive or negative 
views on the telehealth 
intervention and the 
Beck Scale for Suicidal 
Ideation (BSS), 17 item 
Hamilton depression 
scales, Calgary 
depression rating scale, 
Mini mental status exam, 
Scale for assessment 
of positive symptoms, 
Scale for assessment of 
negative symptoms
Monthly adherence to the Health Buddy system 
was 83% (n=20), 92% (n=19) and 89% (n=15) for 
month 1, month 2, and month 3 respectively. Both 
groups exhibited improvement in suicidal ideation. 
The health buddy group BSS score reduced from 
9.8 (SD =6.15) at baseline to 2.44 (SD =5.52) at 
endpoint, whilst the control group score reduced 
from 10.7 (SD =8.24) at baseline to 2.88 (SD =6.71) 
at endpoint. For the subgroup of participants who 
had a life time history of suicide attempt, a trend 
for a higher rate of remission at the 3-month period 
was found for those in the Health Buddy condition 
(16/18) compared to the ICM condition (14/19; log 
rank=2.82; df=1; P=0.093)
Kauppi  
et al.
2015 N=562 Mobile phone Demographic data 
and readmission to 
psychiatric services 
measured by no. of 
healthy days
Overall a total of 2,112 text messages were sent to 
participants, the mean no. of messages selected 
by participants was 10 per month (SD 4.0; range, 
2−25). There was a significant difference found in 
gender and age, with older females and younger 
males preferring greater number of messages. The 
most popular day to receive messages was found 
to be Monday and the least popular timing for 
messages was the weekend
Montes  
et al.
2012 Total 254 patients. 
SMS Group 
N=100; Control 
group N=154
Mobile phone Morisky Green Adherence 
Questionnaire (MAQ)
Mean change in MAQ Score in IG was −1.0 (95% 
CI, −1.02, −0.98) while in the CG the change was 
-0.7 (95% CI, −0.72, −0.68) (P=0.02). Improvement 
was also noted in negative and cognitive 
symptoms and attitude towards medication
Table 1 (continued)
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the detection of early warning signs, through the use of 
SMS based alerts delivered using a mobile phone. The 
clinicians were provided alerts to increase pharmacological 
intervention if there was an increase in scores on the early 
warning signs questionnaire (EWSQ).
Kauppi et al. (27) utilised SMS based user defined 
prompts, relating to medication, follow up appointments 
and daily issues such as hygiene, physical exercise, symptom 
management and other supporting messages during 
discharge from a psychiatric inpatient setting. The frequency 
and timing of the SMS prompts were also defined by 
the user. A total of 562 participants enrolled in the study 
with participants’ receiving a mean total of 10 messages 
a month (SD 4.0; range, 2–25) over the 12-month study 
period. Montes et al. (28) used an SMS based mHealth 
delivery modality for medication adherence, a total of 254 
participants took part in the study. Similarly, Montes et al. (28) 
used an SMS based mHealth delivery modality for 
medication adherence. In this study participant in the IG 
condition received daily reminders to take their medication. 
In contrast, Kasckow et al. (29) assessed the feasibility 
of a telehealth monitoring intervention known as ‘Health 
Buddy’ for suicidal behaviour in a population of recently 
admitted inpatient US veterans aged 18 to 64, diagnosed 
with schizophrenia or schizoaffective disorder and recent 
suicidal ideation. The Health Buddy was a daily use system 
that facilitated symptom assessment and patient-staff 
communication during weekly visits for veterans following 
an intensive case monitoring (ICM) program. The study 
assessed, whether augmentation of ICM with the Health 
Buddy system would result in a significant reduction in 
suicidal ideation comparative to an ICM only group. This 
was reviewed using the beck scale for suicidal ideation (BSS).
Medication adherence
A total of 4 studies looked at medication adherence, with a 
combined sample size of n=921 participants, although the 
study by Kasckow et al. (29) investigated suicidal ideation in 
veterans with schizophrenia using the Health Buddy system. 
The daily monitoring of participants using the Health 
Buddy system included queries about medication adherence, 
which was described by participants as being effective in 
improving their medication adherence. In addition, the 
study by Pijnenborg et al. (25), reported that participants 
who responded to the alerts and achieved their goals had 
significantly lower positive symptoms compared to the non-
responders (t=2.11, P=0.04). It was found that participants 
showed an increase in leisure activities and keeping to 
appointments with their health professionals. However, this 
was not the case for medication adherence and attendance 
at training sessions. These results differed from the study by 
Kauppi et al. (27), Kasckow et al. (29) and Montes et al. (28), 
who found improvements in medication adherence.
Table 1 (continued)
Author Year Population
mHealth delivery 
method
Outcome measures used Main findings
Pijnenborg 
et al.
2010 N=62 Client Motivations for 
Therapy Scale, several 
scales to measure the 
cognitive functioning, 
PANSS, Social 
Functioning Scale and 
Rosenberg Self-Esteem 
Questionnaire
Overall the mean success percentage was 47% 
across all the goal categories during baseline (SD 
27.9), this increased to 62% during the intervention 
(SD 20.1), and reduced to 40% at follow-up 
(SD 31.7). Participants who responded to the 
alerts and achieved their goals had significantly 
lower positive symptoms compared to the non-
responders (t=2:11, P=0.4)
Spaniel  
et al.
2012 Active group: 
N=75; Control 
group: N=71
Mobile phone Clinical Global 
Impression Severity 
and Improvement 
Scales (CGI-S and 
CGI-I), Hayward 7-item 
Medication Compliance 
Rating Scale and GAF 
Scale
Overall, the return rate for the Early Warning 
Signs Questionnaire (EWSQ) was 80% (active 
=79.8%, controls =81.3%), it was reported 
that the individuals who did not receive an 
increase in antipsychotic medication following 
a Pharmacological Intervention Requiring Event 
(PIRE) had an increased risk of hospitalisation (HR 
=10.8; 95% CI, 1.4–80.0; P=0.002)
ICM, intensive case monitoring; IG, intervention groups; HR, hazard ratio; CI, confidence interval.
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Kauppi et al. (27) utilised SMS based user defined 
prompts, relating to medication, follow up appointments 
and daily issues such as hygiene, physical exercise, 
symptom management and other supporting messages 
during discharge from a psychiatric inpatient setting. 
The frequency and timing of the SMS prompts were also 
defined by the user. A total of 562 participants enrolled in 
the study with participants’ receiving a mean total of 10 
messages a month (SD 4.0; range, 2–25) over the 12-month 
study period. The results showed that the most preferable 
timing for the selected messages was at the beginning of 
the week, with participants less likely to prefer receiving 
messages on a weekend. The most selected messages related 
to medication (175 participants), follow up appointments 
(149 participants) and physical exercise (82 participants). 
Furthermore, In the Montes et al. (28) study participants 
who were in the  IG condition significantly improved in 
medication adherence compared to those in the control 
group (CG) Mean change in score in  IG was −1.0 (95% CI: 
−1.02, −0.98) while in the CG the change was −0.7 (95% 
CI: −0.72, −0.68) (P=0.02). In addition, the Montes et al. (28) 
reported that participants in the intervention group held 
more positive views about medications.
ESM
Only one of the studies utilised an ESM based methodology (23). 
The system would use randomly selected data points to 
obtain participant’s symptoms through either; smartphone 
notifications or SMS. This in effect constructed a daily 
record of the participant’s symptoms, enabling them to 
produce a day-to-day symptom profile. Participants in 
the smartphone application condition took significantly 
less time to complete the assessment questions (Mean 
=68.4 seconds, SD =39.5) compared to the SMS condition 
(Mean =325.5 seconds, SD =145.6) (β=0.78, SE =0.09, 
P<0.001). It was also reported that individuals completed 
significantly more notifications in the smartphone condition 
compared to the SMS only condition. There was also a 
significant difference (β=−0.25, SE =0.11, P=0.02) in data 
points completed in the smartphone application condition 
compared to the SMS group with smartphone application 
group completing 69% of entries, (mean =16.5), compared 
to the SMS condition (56% of entries, mean =13.5). There 
was no significant difference in PANSS scores across the 
domains, hallucinations anxiety, grandiosity, delusions, 
paranoia and hopelessness.
Cognitive functioning
The study by Dang et al.  (24) examined cognitive 
functioning and used the N-Back task to assess cognitive 
functioning. In addition, the Wechsler Memory Scale-
Revised (WMS-R) and full versions of the Wechsler 
Adult Intelligence Scale-Revised (WAIS-R) were used 
to assess participants at baseline. The results suggested 
that participants in the experimental group significantly 
improved in accuracy rate at 2-back (Z =−3.27, Pcorrected 
b 0.01), and reaction time in 0, 1 and 2-back (Z =−2.89, 
Pcorrected =0.012; Z =−2.60, Pcorrected =0.048; Z =−2.98, 
Pcorrected =0.012, respectively) from baseline to week 4, 
compared to those in the CG. In addition, Montes 
et al. (28) also looked at cognitive functioning and reported 
improvements in negative symptoms (Baseline =3.3 vs. 
3 months =3.5) and cognitive symptoms (Baseline=3.3 vs. 
3 months =3.5) P<0.05, in the IG compared to the CG 
group on the Severity of illness subscale of the Clinical 
Global Impression-Schizophrenia Scale (CGI-SCH-SI).
In contrast, the study by Pijnenborg et al. (25) looked 
at the efficacy of SMS based prompts to compensate for 
cognitive impairments in schizophrenia. This was done 
through SMS based prompts aimed at improving their 
everyday functioning through setting goals. Pijnenborg 
et al. (25) reported that the mean success percentage was 
47% across all the goal categories during baseline (SD 
27.9), this increased to 62% during the intervention (SD 
20.1), and reduced to 40% at follow-up (SD 31.7). 
Engagement with mHealth technology
The Kasckow et al. (29) study looked at monthly adherence 
to the Health Buddy system which was reported to be 83% 
(n=20), 92% (n=19) and 89% (n=15) for month 1, month 
2, and month 3 respectively. Monthly adherence rates 
were calculated, by adding the number of days participants 
completed the questions divided by the number of days the 
participants were in the study that month. Both groups were 
reported to have shown improvement in suicidal ideation. 
The health buddy group BSS score reduced from 9.8 (SD 
=6.15) at baseline to 2.44 (SD =5.52) at endpoint, whilst the 
CG score reduced from 10.7 (SD =8.24) at baseline to 2.88 
(SD =6.71) at endpoint. No difference in groups was found 
when examining duration to remission (defined as having 
a BSS score =0), however for the subgroup of participants 
with a life time history of suicide attempt, a trend for a 
higher rate of remission at 3 months was reported for those 
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in the Health Buddy condition (16/18), compared to those 
in the ICM condition (14/19; log rank=2.82; df=1; P=0.093). 
No significant differences were detected between groups 
in scores on Calgary Depression Rating Scale, Hamilton 
Depression Rating Scale and Scale for Positive Symptoms 
and Scale for Negative Symptoms were included. However, 
in contrast Spaniel et al. (26) reported, that despite the fact 
that over the study period 17,082 SMS messages were sent 
by participants, it was reported that the study was largely 
unsuccessful, due to poor adherence by investigators to 
the protocol. They reported that only 39% of participants 
received an increase in antipsychotic medication in response 
to increased scores of the EWSQ. 
Feasibility and acceptability 
One of the main results of the included studies was the 
feasibility and acceptability of the mHealth interventions. 
Montes et al. (28) concluded that due to the ease of 
implementation, using mobile phones to prompt medication 
was feasible and acceptable. In addition, the Ainsworth 
et al .  (23) study reported that mobile phones and 
smartphones were acceptable forms of technology. However 
there was shown to be a greater preference by participants 
to a smartphone application compared to a mobile phone. 
It was reported that participants took longer to complete 
each entry in the SMS condition (325.5 seconds, SD 145.6) 
compared to the smartphone application condition (68.4 
seconds, SD 39.5). Overall 67% of participants preferred 
using the smartphone application compared to 13% who 
preferred SMS, 21% of individuals had no preference on 
the delivery method. Furthermore, it was reported that 
71% of participants found using the smartphone application 
easier than the SMS delivery modality, 17% found the SMS 
condition to be easier and 13% had no preference (23).
The studies that used mobile phones were primarily 
used for the sending and receiving of SMS messages, these 
mobile devices had basic functionality such as voice calling, 
gaming, alarm, SMS and vibrate alerts (25,26,28). These 
studies also reported positive evaluations of using mobile 
phone based interventions. Pijnenborg et al. (25), found 
that the 70% of participants viewed the SMS intervention 
as positive, 20% were neutral and 10% held negative 
views. In addition, Pijnenborg et al. (25) reported that 
41% of the participants found the intervention effective, 
33% were neutral and 26% evaluated the intervention as 
ineffective. However, in contrast, Spaniel et al. (26) reported 
that feasibility could only be gauged once there had been 
acceptance of computerised methods and a change in 
clinical thinking. 
In addition, feasibility of the Health Buddy system 
was examined over a 3-month period, with 20 of the 25 
participants able to set up the Health Buddy system. Kasckow 
et al. (29). Of the 25 participants, it was reported that 4 
individuals required some assistance to help with setting up 
the health buddy system. A number of reasons were reported 
for the 5 participants who did not set up the device, such 
as permission from landlord, substance misuse, cognitive 
impairment, phone company debt and transportation 
problems. In addition, Kauppi et al. (27) reported that 
participants preferred messages at the beginning of the 
week. It was suggested that individuals preferred messages 
early in the morning and in accordance to a working week 
format, running through Monday to Friday. 
Risk of bias assessment 
We used the Cochrane collaboration risk of bias instrument (19) 
to measure the risk of bias in the assessment of quality of 
trial reports, which is shown in Figure 2. Only one study had 
low risk of bias (26). All studies included were randomised 
trials however one was a qausi-randomised trial (25). Three 
of the studies described an appropriate method to generate 
the sequence of randomisation or gave the details, however 
the method used in the Pijnenborg et al. (25) was scored 
as high risk. All studies gave the details of withdrawal 
and drop outs. Ainsworth et al. (23) did not report the 
PANSS outcome measures highlighting a risk of bias when 
reporting data on outcomes used in their trial. The study 
by Dang et al. (24) indicated that the methods of the study 
were described in an earlier paper Lu et al. (30), however 
it was unclear as to what methods of randomisation and 
allocation to treatment arm were employed highlighting a 
risk of bias. 
Discussion
The present systematic review is the first to look at mobile 
device interventions for the treatment and assessment of 
psychosis, with a focus on how future research can inform 
the use of mHealth technologies to increase access to 
treatments for SMI such as psychosis globally. Previous 
reviews have focused on telehealth, web based and internet 
interventions (14,15). However, these reviews investigated 
an array of differing delivery modalities such as the internet 
and telephone based land lines. Considering the increasing 
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access to mobile devices globally, mHealth may potentially 
increase access to appropriate mental health care. 
In view of the limited literature on the subject, the 
findings of this review can only help to comment on 
feasibility and acceptability of the mHealth interventions. 
Most studies found that mobile based interventions were 
feasible. Overall, it appears that the strongest evidence 
found, was related to mHealth technologies for medication 
adherence. Kauppi et al. (27) and Montes et al. (28) found 
that using mobile phones to prompt medication was feasible 
and acceptable. Similarly, Kasckow et al. (29) reported no 
significant difference in the clinical measures between the 
groups, however qualitative analysis of end-point surveys 
revealed a mainly positive response from participants in 
the Health Buddy condition with participants describing 
the program as effective in relation to improvement in 
medication adherence, and reduction in symptoms of 
anxiety and depression 
The included studies reported a variety of outcomes. 
These included treatment adherence (28) ,  social 
functioning (25), mobile text message preferences for people 
on antipsychotics (27), experiential sampling (23), cognitive 
impairment (24) relapse prevention (26) and suicidal 
ideation (29). This combined with limited literature on the 
subject means that it is not possible to have any definitive 
findings on the effectiveness of mHealth based interventions 
in improving these outcomes. There was an increase in 
medication adherence; Montes et al. (28) and Pijnenborg 
et al. (25) reported improvement in social functioning. 
This is consistent with literature in other branches of 
medicine (31), where mobile devices have successfully been 
used to improve adherence. 
The mobile phones were primarily used for the sending 
and receiving of SMS messages. (25,26,28). These studies 
also reported positive evaluations of using mobile phone 
based interventions. Pijnenborg et al. (25), found that the 
70% of participants viewed the SMS intervention as positive 
and only 10% held negative views Pijnenborg et al. (25). 
These findings are important and demonstrate that even the 
simple mobile devices can be used for interventions using 
functions such as SMS alerts, voice calling or alarms. This is 
relevant for low resourced settings, where large populations 
Figure 2 Risk of bias assessment diagram.
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may have access to mobile devices with basic functionality. 
However, it must be noted that, delivery of assessment 
questions in the Ainsworth et al. (23) study utilised either 
a mobile App or SMS text messages. It was reported that 
participants took longer to complete each entry in the 
SMS condition compared to the smartphone application 
condition. Overall 67% of participants preferred using the 
smartphone application compared to 13% who preferred 
SMS. This may suggest factors such as usability and user 
experience may be key factors in ensuring a user-friendly 
medium to deliver mHealth intervention, which goes 
beyond basic SMS messaging. 
An innovative use of mHealth is the real-time assessment 
psychosis using an ESM methodology which was conducted 
by Ainsworth et al. (23). The study was based on the 
mHealth interventions engaging with participants in real-
time. Research, in the real-time assessment of psychosis has 
been conducted by Myin-Germeys et al. (32) who described 
the method as ESM. The method looks at the differing 
moods, thoughts and psychotic symptoms of individuals 
which occur in their day to day lives. The method is used 
to construct an understanding of individual’s psychotic 
symptoms with a view to understanding the aetiological 
underpinnings of psychosis in the real-world context (33). 
Methods such as experiential sampling provide greater 
insight into SMI’s, constructing a picture of individual’s 
experiences of psychosis in day-to-day life. These uses, 
however, need to be evaluated in larger well-designed 
studies.
Limitations
The major limitation of the present review is that we 
were only able to identify 7 studies with relatively smaller 
sample sizes. It is unlikely that we missed any studies as 
we used a comprehensive search strategy. However, the 
limited literature shows that it is possible to design and 
conduct studies using mHealth interventions for improving 
treatment adherence, monitoring symptoms, and social 
functioning. Although this data is useful in providing 
evidence for the proof of concept of the potential benefits 
and applicability of mHealth for psychosis, this has not 
been properly evaluated. Furthermore, we were unable 
to find studies which looked at both the assessment and 
treatment of psychosis, using a randomised controlled 
trial design. This is important as interventions which can 
provide assessment and treatment for psychosis in real time 
such as the Depp et al. (21) study can be hugely beneficial to 
individuals with SMI particularly in low resourced settings.
Implications
The utility of mHealth has been shown in a number of 
Non-Communicable disorders globally. For example, 
Piette et al. (34) reported that mobile technologies can 
be used effectively in self-management of hypertensive 
patients to improve outcomes. Tran et al. (35), investigated 
teleconsultation with a software-enabled mobile telephone 
for common skin diseases by a dermatologist, it was 
found that mobile technology enabled greater access to 
dermatological expertise where access is limited. It may 
be possible to employ these methodologies for providing 
teleconsultations with mental health professionals, in areas 
where there is limited access to specialist mental health 
care. This potentially may be of huge benefit to those 
individuals who live in remote or rural areas and areas of 
high deprivation. Similarly, it may be possible to employ 
the cheap and widespread use of SMS messages for public 
health interventions such as reducing stigma associated with 
psychosis.
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Supplementary 
(I) random$ or control or controlled or trial or condition 
or assigned or groups
(II) exp schizophrenia/ or exp psychosis/ (psychotic or 
schizo$ or psychos$ or psychoses) or ((chronic$ or 
sever$) adj5 mental$ adj5 (ill$ or disorder$)) or exp 
psychiatric treatment/ or exp therapy/ or exp therapy/ 
or exp sociotherapy/ or exp clinical study/
(III) (intervention or psychotherapy or rehabilitation or 
training or therapy) or ((psychological or psychosocial 
or psychiat$ or clinical) adj5 (intervention or therap$ 
or rehabilitation or remediat$ or training or clinical 
or care)) or ((cognitive or behav$ or family or focused 
or psycho$ or social$ or education$ or skill$) adj5 
(intervention or therap$ or rehabilitation or remediat$ 
or training))
(IV) smartphone$ OR smart phone$ OR (window? adj3 
phone) OR (window? adj3 mobile) OR nokia OR 
palm OS OR symbian OR iphone OR ipad OR iPod 
touch$ OR m health OR mhealth OR PDA OR 
personal digital assistant? OR android OR blackberr$ 
cellular phone [MeSH] OR phone$ OR telephone$ 
app OR apps OR application? OR software OR 
twitter OR facebook OR telemedicine OR tele 
medicine OR telehealth OR tele health OR ehealth 
OR computerised intervention$ OR computerized 
intervention$ OR e health OR e mail$ OR email$ OR 
Electronic mail OR health technolog$ OR intranet?
Search strategy
